Last reviewed · How we verify
Tangning Tongluo Capsule — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Tangning Tongluo Capsule (Tangning Tongluo Capsule) — Guizhou Bailing Group Pharmaceutical Co Ltd.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Tangning Tongluo Capsule TARGET | Tangning Tongluo Capsule | Guizhou Bailing Group Pharmaceutical Co Ltd | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Tangning Tongluo Capsule CI watch — RSS
- Tangning Tongluo Capsule CI watch — Atom
- Tangning Tongluo Capsule CI watch — JSON
- Tangning Tongluo Capsule alone — RSS
Cite this brief
Drug Landscape (2026). Tangning Tongluo Capsule — Competitive Intelligence Brief. https://druglandscape.com/ci/tangning-tongluo-capsule. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab